SNAI1 and Hepatic fibrosis: The ratio of α-SMA/GAPDH in liver fibrosis model group was higher than that in control group, with 200 mg/μl insulin containing Snail-treated for 96 h, ratio of α-SMA increased significantly in liver fibrosis model group than control group.